UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR™ (levetiracetam) extended-release tablets comparing tolerability vs. levetiracetam immediate release ...
Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...
February 5, 2007 — Levetiracetam, a new-generation antiepileptic drug, is as effective and well-tolerated as carbamazepine when used as first-line monotherapy in newly diagnosed epilepsy, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback